Working… Menu

A Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in Argentina

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03330886
Recruitment Status : Unknown
Verified February 2018 by Hoffmann-La Roche.
Recruitment status was:  Not yet recruiting
First Posted : November 6, 2017
Last Update Posted : February 12, 2018
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 31, 2019
Estimated Study Completion Date : December 31, 2019